949922-33-2 Usage
Uses
Used in Medicinal and Pharmaceutical Research:
Tert-butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate is utilized as a compound of interest in medicinal and pharmaceutical research due to its distinctive structural features. Its potential biological activity makes it a candidate for the development of new drugs, targeting a range of therapeutic areas.
Used in Organic Chemistry Synthesis:
In the field of organic chemistry, tert-butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate serves as a reagent that can be employed in the synthesis of other complex organic molecules. Its unique functional groups and the presence of boron may facilitate novel synthetic pathways and reactions.
Used in Scientific Research:
tert-butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate's structural complexity and the incorporation of boron make tert-butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate an intriguing subject for further study and research across various scientific disciplines. It may lead to advancements in material science, catalysis, and other areas where novel chemical structures are of interest.
Check Digit Verification of cas no
The CAS Registry Mumber 949922-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,9,9,2 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 949922-33:
(8*9)+(7*4)+(6*9)+(5*9)+(4*2)+(3*2)+(2*3)+(1*3)=222
222 % 10 = 2
So 949922-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C21H32BNO4/c1-19(2,3)25-18(24)14-23-11-10-15-12-17(9-8-16(15)13-23)22-26-20(4,5)21(6,7)27-22/h8-9,12H,10-11,13-14H2,1-7H3
949922-33-2Relevant articles and documents
PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES
-
, (2008/06/13)
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues of the Formula: are provided, in which variables are as described herein. Such compounds may be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are parti